Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies (Q28235757)
Jump to navigation
Jump to search
scientific article (publication date: May 2009)
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies |
scientific article (publication date: May 2009) |
Statements
Autologous attenuated T-cell vaccine (Tovaxin) dose escalation in multiple sclerosis relapsing-remitting and secondary progressive patients nonresponsive to approved immunomodulatory therapies (English)
0 references
May 2009
0 references
131
0 references
2
0 references
202-15
0 references